Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Tricyclic 5alpha-reductase inhibitors designed at Merck & Co.

March 14, 2000

Phase III trial of Anogesic as treatment for anal fissure pain commences

March 13, 2000

In vitro and in vivo studies with specific chymase inhibitor suggest potential in atopic dermatitis

March 6, 2000

Wound-healing gene therapy using NAB2

Feb. 29, 2000

Pfizer presents new urokinase inhibitors for wound healing, etc.

Feb. 28, 2000

Pig small intestine submucosa shows efficacy in wound healing

Feb. 25, 2000

Modified oligonucleotides with staggered PS/PO linkages designed at Isis

Feb. 24, 2000

Switch Biotech files patent applications for wound-healing genes

Feb. 23, 2000

Topical tazarotene effective in congenital ichthyosis

Feb. 18, 2000

Antipsoriatic activity of EGF receptor tyrosine kinase inhibitor SU-5271

Feb. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...